Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro

• Published in: Stem cell reviews Vol. 13; no. 3; pp. 321 - 334
• Main Authors: Park, Gun-Seok, Park, Min Hee, Shin, Woojung, Zhao, Connie, Sheikh, Sameer, Oh, So Jung, Kim, Hyun Jung
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2017; Springer Nature B.V
• Subjects: Biochips; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Cell Biology; Digestion; Digestive system; Diseases; Drug metabolism; Ecosystem; Ecosystems; Gastrointestinal Microbiome - physiology; Gastrointestinal tract; Gastrointestinal Tract - microbiology; Humans; Immune system; Infections; Intestinal microflora; Life Sciences; Metabolites; Microbial activity; Microbiota; Microorganisms; Nutrients; Organoids; Physiology; Regenerative Medicine/Tissue Engineering; Stem Cells; In vitro model; Organ-on-a-chip; Organoids; Co-culture; Gut microbiome
• ISSN: 1550-8943; 2629-3269; 1558-6804; 2629-3277
• DOI: 10.1007/s12015-017-9739-z

The human gut microbiome performs prodigious physiological functions such as production of microbial metabolites, modulation of nutrient digestion and drug metabolism, control of immune system, and prevention of infection. Paradoxically, gut microbiome can also negatively orchestrate the host responses in diseases or chronic disorders, suggesting that the regulated and balanced host-gut microbiome crosstalk is a salient prerequisite in gastrointestinal physiology. To understand the pathophysiological role of host-microbiome crosstalk, it is critical to recreate in vivo relevant models of the host-gut microbiome ecosystem in human. However, controlling the multi-species microbial communities and their uncontrolled growth has remained a notable technical challenge. Furthermore, conventional two-dimensional (2D) or 3D culture systems do not recapitulate multicellular microarchitectures, mechanical dynamics, and tissue-specific functions. Here, we review recent advances and current pitfalls of in vitro and ex vivo models that display human GI functions. We also discuss how the disruptive technologies such as 3D organoids or a human organ-on-a-chip microphysiological system can contribute to better emulate host-gut microbiome crosstalks in health and disease. Finally, the medical and pharmaceutical significance of the gut microbiome-based personalized interventions is underlined as a future perspective.